Development of oral lesions in human immunodeficiency virus-infected transfusion recipients and hemophiliacs.
The authors used multivariate repeated-measures transition models to identify risk factors for two oral lesions related to human immunodeficiency virus (HIV-candidiasis and hairy leukoplakia-in 152 HIV-infected blood transfusion recipients and hemophiliacs.
Subjects were examined for occurrences of these lesions every 6 months from July 1985 through March 1993, yielding 1,076 study visits.
It was found that, after adjustment for the CD4 : CD8 T-lymphocyte ratio, patients with a history of candidiasis in the previous 18 months were at high risk of lesion recurrence.
This risk increased with the number of prior episodes and with the recency of the episode (s).
A history of hairy leukoplakia was less predictive of persistence of that lesion after adjustment for significant risk factors (including candidiasis and use of antifungal agents at the current examination, a low CD4 : CD8 cell ratio, and age less than 40 years).
The authors also found a high coprevalence of candidiasis and hairy leukoplakia in these subjects.
These results suggest that HIV-infected patients with oral candidiasis should be carefully monitored for subsequent episodes over the next 12-18 months, and patients with either oral candidiasis or hairy leukoplakia and a low CD4 : CD8 cell ratio should be carefully examined for the other type of lesion as well.
Mots-clés Pascal : Leucoplasie chevelue, Candidose, Mycose, Infection, Hémophilie, SIDA, Virose, Transfusion, Homme, Epidémiologie, Lésion, Cavité buccale, Facteur risque, Californie, Etats Unis, Amérique du Nord, Amérique, Hémopathie, Coagulopathie, Maladie héréditaire, Immunopathologie, Immunodéficit
Mots-clés Pascal anglais : Hairy leukoplakia, Candidiasis, Mycosis, Infection, Hemophilia, AIDS, Viral disease, Transfusion, Human, Epidemiology, Lesion, Oral cavity, Risk factor, California, United States, North America, America, Hemopathy, Coagulopathy, Genetic disease, Immunopathology, Immune deficiency
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 97-0180923
Code Inist : 002B10B02. Création : 21/05/1997.